Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19

Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients

(2021) Stuart Lance Cohen et al.   THROMBOSIS AND HAEMOSTASIS

Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients

(2021) Gary E. Raskob et al.   Journal of the American Heart Association

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

(2021) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Anticoagulation in COVID-19: reaction to the ACTION trial

(2021) Jeffrey S Berger et al.   LANCET

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

(2021) Renato D Lopes et al.   LANCET

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

(2021)   NEW ENGLAND JOURNAL OF MEDICINE

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

(2021)   NEW ENGLAND JOURNAL OF MEDICINE

Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series

(2020) Sigurd F. Lax et al.   ANNALS OF INTERNAL MEDICINE

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

(2020) Dominic Wichmann et al.   ANNALS OF INTERNAL MEDICINE

Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence

(2020) Julien Poissy et al.   CIRCULATION

Coagulopathy of Coronavirus Disease 2019

(2020) Toshiaki Iba et al.   CRITICAL CARE MEDICINE

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

(2020) Julie Helms et al.   INTENSIVE CARE MEDICINE

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

(2020) Behnood Bikdeli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Hospitalized COVID-19 Patients and Venous Thromboembolism

(2020) Alex C. Spyropoulos et al.   CIRCULATION

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System

(2020) Seda Bilaloglu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis

(2020) F.A. Klok et al.   THROMBOSIS RESEARCH

Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19

(2020) Carmen Fernández-Capitán et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review

(2020) Lucia Gozzo et al.   Frontiers in Pharmacology

Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism

(2018) Farès Moustafa et al.   THROMBOSIS RESEARCH